October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
Sampling restrictions modestly alter prescribing behavior
October 19th 2010Implementation of a policy restricting drug sampling and pharmaceutical industry detailing in a small rural clinic resulted in modest reductions in the prescription of branded and promoted drugs, according to research published in the September/October issue of the "Annals of Family Medicine."
Researchers identify risk factors for ER visits in chronic opioid users
October 19th 2010Use of Schedule II opioids, back pain, headache, and pre-existing substance use disorders are all associated with alcohol- or drug-related encounters and emergency department visits in adults who have taken prescribed opioids for at least 90 days, according to a study published in the Sept. 13 issue of the Archives of Internal Medicine, HealthDay News reports.
Maryland researchers get grant to develop drug to treat cocaine addiction
October 19th 2010The National Institutes of Health?s National Institute on Drug Abuse awarded a 5-year, $3.7 million research grant to Jia Bei Wang, PhD, a professor of pharmaceutical sciences at The University of Maryland School of Pharmacy to develop a drug to treat cocaine addiction.
Lower BP goals set for blacks to manage hypertension
October 19th 2010The updated International Society on Hypertension in Blacks consensus statement on the management of hypertension in this population places a major emphasis on comprehensive assessment and appropriate risk stratification of individual patients with hypertension, according to a report published online Oct. 4 in Hypertension and reported by HealthDay News.
Prophylactic antivirals reduce corneal disease recurrences
October 19th 2010Individuals with ocular herpes simplex virus treated with prophylactic oral antibiotics appear to be at a lower risk of recurrence of epithelial keratitis, stromal keratitis, conjunctivitis, and blepharitis, according to research published in the September issue of the Archives of Ophthalmology, HealthDay News reported.
No benefit to early chemo for ovarian cancer relapse based on raised C125 concentration alone
October 19th 2010For women whose ovarian cancer has been in remission, restarting chemotherapy early on the basis of heightened serum CA125 concentration does not improve survival compared with postponing treatment until symptoms of relapse appear, according to a study published in the Oct. 2, cancer-themed issue of The Lancet.
FDA warns 3 companies over unproven claims on mouth rinses
October 19th 2010FDA has issued warning letters to three companies that manufacture mouth-rinse products and market them with claims that they remove plaque above the gum line or promote healthy gums. These claims suggest the products are effective in preventing gum disease when no such benefit has been demonstrated.
FDA warns about increased risk of thigh-bone fracture with bisphosphonates
October 19th 2010FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.
FDA committee recommends approval of dabigatran for stroke prevention in atrial fibrillation
October 19th 2010FDA's Cardiovascular and Renal Drugs Advisory Committee voted 9 to 0 on Sept. 20 in favor of approving dabigatran etexilate (Pradaxa) for stroke prevention in patients with atrial fibrillation.
FDA orders halt to production and marketing of unapproved single-ingredient oral colchicine
October 19th 2010FDA has requested that all companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever, stop manufacturing this drug.
FDA approves first oral MS drug, Novartis' fingolimod
October 19th 2010FDA has approved the oral multiple sclerosis treatment fingolimod 0.5 mg, as a first-line treatment for relapsing forms of multiple sclerosis. The approval makes fingolimod the first oral treatment indicated for relapsing forms of MS available in the United States.
How useful is consumer medication information for prescription drugs?
October 15th 2010Problems with the content and format of consumer medical information distributed with prescription drugs at retail pharmacies are the primary barriers to providing appropriate information to patients, a recent evaluation suggests. The reading level and length of CMI were also cited as shortcomings.
APhA partners with Kaiser to offer MTM services to employees
October 15th 2010Partnering with Kaiser Foundation Health Plan of the Mid-Atlantic States, the American Pharmacists Association is offering coverage of medication therapy management services provided by pharmacists to employees who are members of Kaiser Permanente.
NCPA to launch site for independent pharmacy buyers and sellers
October 15th 2010A new website sponsored by the National Community Pharmacists Association, www.PharmacyMatching.com, will bring together independent pharmacy owners preparing to sell their pharmacies, pharmacy owners who desire additional stores, and entrepreneurs seeking to become pharmacy owners.
Personal care products: The unmentionables
October 15th 2010Does she or doesn't she? Only her drugstore knows for sure. Even in today's racy culture, certain products are not discussed in polite company. Yet even blushworthy personal care products are essential, and their manufacturers are tuned to the preferences of 78 million style-conscious Baby Boomers.
FDA restricts access to Avandia, cites increased cardiovascular risks
October 15th 2010FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.
Women in healthcare get a website of their own
October 15th 2010The need to find balance in her own life led Anna Garrett, PharmD, to establish the National Association for Women in Health Care, an organization committed to helping nurses, pharmacists, and other women healthcare professionals take care of themselves.
History of diabetes treatment chronicled in New York Historical Society exhibition
October 15th 2010Recalling the desperate fight for life that was waged by juvenile diabetes patients not even a century ago, "Breakthrough: The Dramatic Story of the Discovery of Insulin" will be on view at the New York Historical Society from October 2010 through January 2011.